Astrana Health (NASDAQ:ASTH) Reaches New 12-Month High – Time to Buy?

Astrana Health, Inc. (NASDAQ:ASTH) shares reached a new 52-week high on Thursday . The company traded as high as $40.13 and last traded at $39.90, with a volume of 341269 shares traded. The stock had previously closed at $38.73.

Analysts Set New Price Targets

A number of equities analysts have issued reports on ASTH shares. Barclays upgraded Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $37.00 to $50.00 in a research note on Tuesday, May 26th. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. BTIG Research reaffirmed a “buy” rating and set a $50.00 target price on shares of Astrana Health in a research report on Tuesday, June 2nd. Needham & Company LLC upped their price target on Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Finally, Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Stock Up 2.7%

The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The stock’s 50-day simple moving average is $34.27 and its 200-day simple moving average is $27.32. The firm has a market capitalization of $2.22 billion, a P/E ratio of 65.47 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm had revenue of $965.10 million for the quarter, compared to analysts’ expectations of $949.21 million. During the same quarter last year, the firm earned $0.42 EPS. The company’s quarterly revenue was up 55.6% compared to the same quarter last year. As a group, research analysts predict that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. 325 Capital LLC grew its stake in Astrana Health by 54.0% in the 4th quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock valued at $45,627,000 after purchasing an additional 645,123 shares during the period. State Street Corp raised its position in Astrana Health by 6.2% in the fourth quarter. State Street Corp now owns 1,675,516 shares of the company’s stock worth $41,570,000 after acquiring an additional 98,064 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Astrana Health by 12.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,368,079 shares of the company’s stock valued at $33,545,000 after acquiring an additional 152,267 shares during the period. Geode Capital Management LLC raised its holdings in shares of Astrana Health by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 1,028,168 shares of the company’s stock worth $25,513,000 after purchasing an additional 12,212 shares during the period. Finally, Wellington Management Group LLP lifted its stake in Astrana Health by 418.3% in the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock valued at $18,331,000 after purchasing an additional 596,293 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.